聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 30 分钟 19 秒 前

CMS Further Improves Reimbursement for Lutonix DCB for Outpatient Use

周二, 06/09/2015 - 16:24
MURRAY HILL, N.J.--(Healthcare Sales & Marketing Network)--C. R. Bard, Inc. (BCR) today announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has improved the pass-through payment for the Lutonix® drug-coated balloon (DCB) under the ...
Devices, Interventional, Reimbursement
C. R. Bard, Lutonix, drug-coated balloon, PTCA

Luqa Pharmaceuticals Completes US$15M Series A Financing

周二, 06/09/2015 - 16:20
HONG KONG, June 9, 2015 -- (Healthcare Sales & Marketing Network) --Luqa Pharmaceuticals, a China specialty care company that markets innovative solutions in dermatology and other specialty areas, announces the completion of a US$15 million round of fund ...
Biopharmaceuticals, Dermatology, Venture Capital
Luqa Pharmaceuticals

Tarsis Lopez joins Astellas Corporate Affairs

周二, 06/09/2015 - 16:17
NORTHBROOK, Ill., June 9, 2015 -- (Healthcare Sales & Marketing Network) -- Astellas today announced that Tarsis Lopez has been appointed to the role of associate director, external and digital communications, as part of the newly formed Corporate Affairs...
Biopharmaceuticals, Personnel
Astellas

Elekta CE Marks Leksell Gamma Knife(R) Icon(TM), designed to treat a more expansive range of cranial targets

周二, 06/09/2015 - 16:13
France’s University Hospital La Timone first to install Leksell Gamma Knife Icon, Elekta’s latest generation cranial radiosurgery system STOCKHOLM, Sweden--(Healthcare Sales & Marketing Network)--Elekta has CE marked its Leksell Gamma Knife® Icon™ ...
Devices, Oncology, Neurosurgery, Regulatory, Product Launch
Elekta, Gamma Knife, radiotherapy, radiosurgery

Cohera Medical, Inc.(R) Receives Expedited Access Pathway Designation from FDA for Sylys(R) Surgical Sealant

周二, 06/09/2015 - 16:08
Breakthrough Surgical Sealant Designed to Help Reduce Anastomotic Leaks for Patients Undergoing Gastrointestinal Resections PITTSBURGH, June 9, 2015 -- (Healthcare Sales & Marketing Network) -- Cohera Medical, Inc.®, a leading innovator and develop...
Devices, Surgery, FDA
Cohera Medical, Sylys, Surgical Sealant, TissuGlu, Surgical Adhesive

Healthcare Executive Noel Mijares to Join Millennium Healthcare Inc. as New CEO

周二, 06/09/2015 - 16:04
MELVILLE, NY--(Healthcare Sales & Marketing Network) - Millennium Healthcare Inc. (OTCQB: MHCC), a healthcare services and medical device distribution company, today announced that industry executive Noel Mijares will join the company as its new Chief Exec...
Devices, Distribution, Personnel
Millennium Healthcare

Opexa Hires Experienced Pharmaceutical Executive as Vice President of Business Development

周二, 06/09/2015 - 15:59
THE WOODLANDS, Texas--(Healthcare Sales & Marketing Network)--Opexa Therapeutics, Inc. (OPXA), a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders including multiple sclerosis (MS) and neuromyelitis optica (NMO), is...
Biopharmaceuticals, Personalized Medicine, Personnel
Opexa Therapeutics, immunotherapy, multiple sclerosis

Amicus Therapeutics Strengthens Executive Leadership Team

周一, 06/08/2015 - 15:21
Adds Two Former Heads of Global Marketing From Leading Rare Disease Companies in Fabry Field Hung Do, Ph.D. Promoted to Chief Science Officer CRANBURY, N.J., June 8, 2015 -- (Healthcare Sales & Marketing Network) -- Amicus Therapeutics (FOLD), a bio...
Biopharmaceuticals, Personnel
Amicus Therapeutics, migalastat, Fabry disease, Pompe disease

Spero Completes $30 Million Financing

周一, 06/08/2015 - 15:19
Expands focus on Gram-negative bacteria by adding Potentiator program to pipeline of novel antibiotic compounds CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel thera...
Biopharmaceuticals, Venture Capital, Personnel
Spero Therapeutics, antibiotic

Conatus Pharmaceuticals Appoints Jean L. Chan as Vice President, Clinical Development

周一, 06/08/2015 - 15:16
SAN DIEGO, June 8, 2015 -- (Healthcare Sales & Marketing Network) -- Conatus Pharmaceuticals Inc. (CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced the appointment of...
Biopharmaceuticals, Personnel
Conatus Pharmaceuticals, emricasan

Alnylam Appoints David-Alexandre Gros, M.D., Senior Vice President, Chief Business Officer

周一, 06/08/2015 - 15:14
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Alnylam Pharmaceuticals, Inc. (ALNY), a leading RNAi therapeutics company, today announced the appointment of David-Alexandre “DA” Gros, M.D. to the position of Senior Vice President, Chief Business...
Biopharmaceuticals, Personnel
Alnylam Pharmaceuticals, RNAi, RNA interference

Largest Outpatient Imaging Center in the U.S. Installs First Toshiba Celesteion PET/CT System

周五, 06/05/2015 - 15:24
Steinberg Diagnostic Improves Patient Care and Establishes Local Leadership in Molecular Imaging TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--One of the few PET/CT capable imaging facilities in the Las Vegas area, Steinberg Diagnostic Medica...
Devices, Radiology, Oncology, Product Launch
Toshiba America Medical Systems, Celesteion, PET/CT

Cardinal Health To Acquire The Harvard Drug Group For $1.115 Billion

周五, 06/05/2015 - 15:16
Acquisition of $450 million pharmaceutical distributor increases generics scale and reach Non-GAAP(1) diluted earnings per share from continuing operations accretion expected to be greater than $0.15 in fiscal 2016, more than $0.20 in fiscal 2017; accre...
Biopharmaceuticals, Devices, Distribution, Acquisitions
Cardinal Health, Harvard Drug Group

Ultragenyx Appoints Dennis Huang as Chief Technical Operations Officer and Senior Vice President

周四, 06/04/2015 - 16:22
NOVATO, Calif., June 4, 2015 -- (Healthcare Sales & Marketing Network) -- Ultragenyx Pharmaceutical Inc. (RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced it has appointed Den...
Biopharmaceuticals, Personnel
Ultragenyx Pharmaceutical

Alliqua BioMedical, Inc. Appoints Nino Pionati as Chief Strategy and Marketing Officer

周三, 06/03/2015 - 15:01
LANGHORNE, Pa., June 3, 2015 -- (Healthcare Sales & Marketing Network) -- Alliqua BioMedical, Inc. (ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care products, today announced the appointment of Nino Pionati to the p...
Devices, Wound Care, Personnel
Alliqua BioMedical, SilverSeal, Hydress, wound dressing

Amicus Therapeutics Submits Marketing Authorization Application (MAA) for Full Approval of Fabry Monotherapy Galafold(TM) (Migalastat) in European Union

周三, 06/03/2015 - 14:42
MAA Submission Under "Accelerated Assessment" Brand Name Galafold(TM) Approved by Regulatory Authorities in EU and U.S. CRANBURY, N.J., June 3, 2015 -- (Healthcare Sales & Marketing Network) -- Amicus Therapeutics (FOLD), a biopharmaceutica...
Biopharmaceuticals, Regulatory
Amicus Therapeutics, Galafold, migalastat, Fabry Disease

Ardelyx to Raise $77.8 Million in a Private Placement and Announces New Product Candidate for the Treatment of Hyperkalemia to Begin Clinical Development in Mid-2015

周三, 06/03/2015 - 14:31
Ardelyx to Pursue an Accelerated 505b(2) Regulatory Pathway for RDX022 with Initiation of Phase 3 Program to Begin as Early as Second Half 2016 Conference Call and Webcast Today at 8:30am ET FREMONT, Calif., June 3, 2015 -- (Healthcare Sales & Market...
Biopharmaceuticals, Venture Capital
Ardelyx, RDX022, hyperkalemia

Ardelyx Regains Worldwide Development and Commercialization Rights for Its Late-Stage Development Candidate, Tenapanor, and Related Portfolio of NHE3 Compounds

周三, 06/03/2015 - 14:24
Ardelyx to Initiate a Phase 3 Clinical Program in IBS-C Patients in the Fourth Quarter of 2015 Conference Call and Webcast Today at 8:30 am ET FREMONT, Calif., June 3, 2015 -- (Healthcare Sales & Marketing Network) -- Ardelyx, Inc. (ARDX), a clinica...
Biopharmaceuticals, Gastroenterology, Acquisitions
Ardelyx, AstraZeneca, NHE3 inhibitor, tenapanor

ZIOPHARM Announces Caesar J. Belbel, Chief Legal Officer, Appointed Chief Operating Officer

周二, 06/02/2015 - 14:44
BOSTON, June 2, 2015 -- (Healthcare Sales & Marketing Network) -- ZIOPHARM Oncology, Inc. (ZIOP), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that Caesar J. Belbel, Executive Vice Pr...
Biopharmaceuticals, Oncology, Personnel
ZIOPHARM Oncology

Advanced fPAT Imaging Announces Clinical First for the JBI-360(TM) Breast Imaging System

周二, 06/02/2015 - 14:37
GAINESVILLE, FL--(Healthcare Sales & Marketing Network) - Advanced fPAT Imaging Inc. (AFPII), a new medical device company focused on early detection of breast cancer and now disease staging, announced today that its JBI-360 breast imaging system was able ...
Devices, Oncology
Advanced fPAT Imaging, JBI-360, Functional PhotoAcoustic Tomography, fPAT

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong